Clinical Updates
Rheumatology
FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality
Food and Drug Administration | May 30, 2019
Most read this week
A variety of information related to Medicine and Health Care. It's all here.
